InsightfulValue
← Home

Novo Nordisk
Novo Nordisk

Pharma / Pharmaceuticals and Healthcare


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

Novo Nordisk

πŸ“Š Get full analytics about Novo Nordisk

Sign up for free or log in

πŸ†“ Discover "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free eBook!

Price
Live  
Overview
Novo Nordisk is a global healthcare company specializing in the development, manufacture, and distribution of pharmaceutical products and medical devices. It was founded in Denmark in 1923 and has since expanded to become one of the largest and most well-known companies in the healthcare industry.
The company's main focus is on developing treatments for diabetes, obesity, and other serious chronic conditions. It is also involved in the production of insulin, which is a hormone used to regulate blood sugar levels in people with diabetes.
Novo Nordisk operates in more than 80 countries worldwide and employs over 45,000 people. It has research and development facilities in several countries, including Denmark, the United States, China, and India.
The company is committed to making a positive impact on society and follows a triple bottom line approach, incorporating social, environmental, and financial considerations into its business strategy. This includes a focus on sustainable environmental practices, ethical business conduct, and community engagement.
Novo Nordisk is also recognized for its strong corporate social responsibility efforts, including partnerships with organizations such as the World Diabetes Foundation and the International Diabetes Federation. It has also received recognition for its commitment to diversity and inclusion in the workplace.
In addition to its primary focus on diabetes and obesity, Novo Nordisk has expanded its portfolio to include products for the treatment of rare blood and endocrine disorders and growth disorders. It has also recently entered the field of cardiovascular disease and chronic kidney disease.
Overall, Novo Nordisk continues to be a leader in the healthcare industry, dedicated to improving the lives of patients and making a positive impact on global health.
What is special about the company?
Novo Nordisk

πŸ“ˆ Want to read more about Novo Nordisk?

Sign up for free or log in

🎁 Free download! "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

MS4gRm9jdX Mgb24gZGlh YmV0ZXMgYW 5kIG90aGVy IGNocm9uaW MgZGlzZWFz ZXM6IE5vdm 8gTm9yZGlz ayBpcyBhIG dsb2JhbCBo ZWFsdGhjYX JlIGNvbXBh bnkgdGhhdC BzcGVjaWFs aXplcyBpbi Bwcm9kdWNp bmcgYW5kIG RldmVsb3Bp bmcgbWVkaW NhdGlvbnMg Zm9yIGRpYW JldGVzIGFu ZCBvdGhlci BjaHJvbmlj IGRpc2Vhc2 VzLCBzdWNo IGFzIG9iZX NpdHkgYW5k IHJhcmUgYm xvb2QgYW5k IGVuZG9jcm luZSBkaXNv cmRlcnMuIF RoaXMgZm9j dXMgYWxsb3 dzIHRoZW0g dG8gaGF2ZS BhIGRlZXAg dW5kZXJzdG FuZGluZyBv ZiB0aGVzZS BkaXNlYXNl cyBhbmQgcH JvdmlkZSBz cGVjaWFsaX plZCB0cmVh dG1lbnQgb3 B0aW9ucyBm b3IgcGF0aW VudHMuPGJy PjIuIFBpb2 5lZXJzIGlu IGluc3VsaW 4gcHJvZHVj dGlvbjogTm 92byBOb3Jk aXNrIHdhcy BvbmUgb2Yg dGhlIGZpcn N0IGNvbXBh bmllcyB0by BzdGFydCBw cm9kdWNpbm cgaW5zdWxp biwgYSBsaW ZlLXNhdmlu ZyBtZWRpY2 F0aW9uIGZv ciBwZW9wbG Ugd2l0aCBk aWFiZXRlcy 4gVGhleSBo YXZlIGJlZW 4gY29udGlu dW91c2x5IG ltcHJvdmlu ZyBhbmQgaW 5ub3ZhdGlu ZyB0aGVpci BpbnN1bGlu IHByb2R1Y3 RzIGZvciBv dmVyIDk1IH llYXJzLjxi cj4zLiBTdH JvbmcgY29t bWl0bWVudC B0byByZXNl YXJjaCBhbm QgZGV2ZWxv cG1lbnQ6IE 5vdm8gTm9y ZGlzayBpbn Zlc3RzIHNp Z25pZmljYW 50bHkgaW4g cmVzZWFyY2 ggYW5kIGRl dmVsb3BtZW 50IHRvIGlu bm92YXRlIG FuZCBpbXBy b3ZlIHRoZW lyIHByb2R1 Y3RzLiBUaG V5IGhhdmUg Y29sbGFib3 JhdGlvbnMg d2l0aCBsZW FkaW5nIHVu aXZlcnNpdG llcyBhbmQg cmVzZWFyY2 ggaW5zdGl0 dXRpb25zLC BhbmQgdGhl aXIgcmVzZW FyY2ggYW5k IGRldmVsb3 BtZW50IGVm Zm9ydHMgaG F2ZSByZXN1 bHRlZCBpbi B0aGUgZGV2 ZWxvcG1lbn Qgb2YgbWFu eSBpbm5vdm F0aXZlIHRy ZWF0bWVudH MuPGJyPjQu IFN1c3RhaW 5hYmxlIHBy YWN0aWNlcz ogTm92byBO b3JkaXNrIG lzIGNvbW1p dHRlZCB0by Bjb25kdWN0 aW5nIGJ1c2 luZXNzIGlu IGFuIGVudm lyb25tZW50 YWxseSBhbm Qgc29jaWFs bHkgcmVzcG 9uc2libGUg bWFubmVyLi BUaGV5IGhh dmUgc2V0IG FtYml0aW91 cyBnb2Fscy B0byByZWR1 Y2UgdGhlaX IgZW52aXJv bm1lbnRhbC BpbXBhY3Qs IHByb21vdG Ugc3VzdGFp bmFibGUgc2 91cmNpbmcs IGFuZCBpbX Byb3ZlIHRo ZWlyIHNvY2 lhbCBwZXJm b3JtYW5jZS 48YnI+NS4g UGF0aWVudC 1jZW50cmlj IGFwcHJvYW NoOiBOb3Zv IE5vcmRpc2 sgcHV0cyBw YXRpZW50cy BhdCB0aGUg Y2VudGVyIG 9mIHRoZWly IGJ1c2luZX NzLiBUaGV5 IHdvcmsgY2 xvc2VseSB3 aXRoIHBhdG llbnQgb3Jn YW5pemF0aW 9ucyB0byB1 bmRlcnN0YW 5kIHRoZSBu ZWVkcyBhbm QgY2hhbGxl bmdlcyBmYW NlZCBieSBw ZW9wbGUgbG l2aW5nIHdp dGggY2hyb2 5pYyBkaXNl YXNlcywgYW 5kIHVzZSB0 aGF0IGtub3 dsZWRnZSB0 byBkZXZlbG 9wIGltcGFj dGZ1bCBzb2 x1dGlvbnMu PGJyPjYuIE dsb2JhbCBy ZWFjaDogV2 l0aCBhIHBy ZXNlbmNlIG luIG1vcmUg dGhhbiAxNz AgY291bnRy aWVzLCBOb3 ZvIE5vcmRp c2sgcmVhY2 hlcyBhIGxh cmdlIG51bW JlciBvZiBw YXRpZW50cy Bhcm91bmQg dGhlIHdvcm xkLiBUaGV5 IGhhdmUgYS BzdHJvbmcg c2FsZXMgYW 5kIG1hcmtl dGluZyBuZX R3b3JrIGFu ZCBwYXJ0bm Vyc2hpcHMg d2l0aCBsb2 NhbCBvcmdh bml6YXRpb2 5zIHRvIGVu c3VyZSBhY2 Nlc3NpYmls aXR5IG9mIH RoZWlyIHBy b2R1Y3RzIH RvIHBhdGll bnRzIGdsb2 JhbGx5Ljxi cj43LiBDb3 Jwb3JhdGUg c29jaWFsIH Jlc3BvbnNp YmlsaXR5Oi BOb3ZvIE5v cmRpc2sgaG FzIGEgc3Ry b25nIGNvbW 1pdG1lbnQg dG8gbWFraW 5nIGEgcG9z aXRpdmUgaW 1wYWN0IGlu IHRoZSBjb2 1tdW5pdGll cyB0aGV5IG 9wZXJhdGUg aW4uIFRoZX kgaGF2ZSB2 YXJpb3VzIG luaXRpYXRp dmVzIHRvIG FkZHJlc3Mg aXNzdWVzIH N1Y2ggYXMg ZWR1Y2F0aW 9uLCBhY2Nl c3MgdG8gaG VhbHRoY2Fy ZSwgYW5kIG NvbW11bml0 eSBkZXZlbG 9wbWVudC48 YnI+OC4gRW 1wbG95ZWUg ZW5nYWdlbW VudCBhbmQg ZGV2ZWxvcG 1lbnQ6IFRo ZSBjb21wYW 55IHZhbHVl cyBpdHMgZW 1wbG95ZWVz IGFuZCBoYX MgYSB3b3Jr IGN1bHR1cm UgdGhhdCBw cm9tb3Rlcy BkaXZlcnNp dHksIGluY2 x1c2lvbiwg YW5kIGVtcG xveWVlIGRl dmVsb3BtZW 50LiBUaGV5 IG9mZmVyIH ZhcmlvdXMg dHJhaW5pbm cgYW5kIGRl dmVsb3BtZW 50IHByb2dy YW1zIGFuZC BlbmNvdXJh Z2UgYSBoZW FsdGh5IHdv cmstbGlmZS BiYWxhbmNl Ljxicj45Li BTdHJvbmcg ZmluYW5jaW FsIHBlcmZv cm1hbmNlOi BOb3ZvIE5v cmRpc2sgaG FzIGEgc29s aWQgZmluYW 5jaWFsIHBv c2l0aW9uLC B3aXRoIGNv bnNpc3Rlbn QgcmV2ZW51 ZSBhbmQgcH JvZml0IGdy b3d0aCBvdm VyIHRoZSB5 ZWFycy4gVG hpcyBlbmFi bGVzIHRoZW 0gdG8gcmVp bnZlc3QgaW 4gcmVzZWFy Y2ggYW5kIG RldmVsb3Bt ZW50IGFuZC BmdWxmaWxs IHRoZWlyIG NvbW1pdG1l bnRzIHRvd2 FyZHMgcGF0 aWVudHMgYW 5kIGNvbW11 bml0aWVzLj xicj4xMC4g QXdhcmRzIG FuZCByZWNv Z25pdGlvbj ogTm92byBO b3JkaXNrIG hhcyByZWNl aXZlZCBudW 1lcm91cyBh d2FyZHMgYW 5kIHJlY29n bml0aW9uIG ZvciB0aGVp ciBpbm5vdm F0aW9ucywg c3VzdGFpbm FiaWxpdHkg cHJhY3RpY2 VzLCBhbmQg ZW1wbG95ZW Ugc2F0aXNm YWN0aW9uLi BUaGlzIGZ1 cnRoZXIgaG lnaGxpZ2h0 cyB0aGVpci BkZWRpY2F0 aW9uIHRvIG 1ha2luZyBh IHBvc2l0aX ZlIGltcGFj dCBvbiBwYX RpZW50cywg ZW1wbG95ZW VzLCBhbmQg c29jaWV0eS 4=
What the company's business model?
Novo Nordisk

πŸ“ˆ Want to read more about Novo Nordisk?

Sign up for free or log in

⚑ Instantly access "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

Tm92byBOb3 JkaXNrIGlz IGEgZ2xvYm FsIGhlYWx0 aGNhcmUgY2 9tcGFueSB0 aGF0IHNwZW NpYWxpemVz IGluIHRoZS Bwcm9kdWN0 aW9uIGFuZC BkZXZlbG9w bWVudCBvZi BwaGFybWFj ZXV0aWNhbC Bwcm9kdWN0 cyBhbmQgbW VkaWNhbCBk ZXZpY2VzLi BUaGVpciBi dXNpbmVzcy Btb2RlbCBm b2N1c2VzIG 9uIHRocmVl IG1haW4gYX JlYXM6IGRp YWJldGVzIG NhcmUsIG9i ZXNpdHksIG FuZCByYXJl IGJsb29kIG FuZCBlbmRv Y3JpbmUgZG lzb3JkZXJz Ljxicj4xLi BEaWFiZXRl cyBDYXJlOi BOb3ZvIE5v cmRpc2sgaX MgdGhlIG1h cmtldCBsZW FkZXIgaW4g ZGlhYmV0ZX MgY2FyZSwg cHJvdmlkaW 5nIGEgd2lk ZSByYW5nZS BvZiBwcm9k dWN0cyBmb3 IgdGhlIHRy ZWF0bWVudC BvZiBib3Ro IHR5cGUgMS BhbmQgdHlw ZSAyIGRpYW JldGVzLiBU aGlzIGluY2 x1ZGVzIGlu c3VsaW4sIG 9yYWwgYW50 aWRpYWJldG ljIGRydWdz LCBhbmQgZG V2aWNlcyBz dWNoIGFzIG luc3VsaW4g cGVucyBhbm QgcHVtcHMu IFRoZSBjb2 1wYW554oCZ cyBnb2FsIG lzIHRvIGlt cHJvdmUgdG hlIGxpdmVz IG9mIHBlb3 BsZSBsaXZp bmcgd2l0aC BkaWFiZXRl cyBieSBwcm 92aWRpbmcg aW5ub3ZhdG l2ZSBhbmQg ZWZmZWN0aX ZlIHRyZWF0 bWVudHMuPG JyPjIuIE9i ZXNpdHk6IE 5vdm8gTm9y ZGlzayBhbH NvIGhhcyBh IHN0cm9uZy Bmb2N1cyBv biBvYmVzaX R5LCBhIG1h am9yIHJpc2 sgZmFjdG9y IGZvciBkZX ZlbG9waW5n IHR5cGUgMi BkaWFiZXRl cy4gVGhlIG NvbXBhbnkg b2ZmZXJzIG EgcmFuZ2Ug b2YgbWVkaW NpbmVzIGFu ZCB3ZWlnaH QgbWFuYWdl bWVudCBwcm 9ncmFtcyB0 byBoZWxwIH Blb3BsZSB3 aXRoIG9iZX NpdHkgYWNo aWV2ZSBhbm QgbWFpbnRh aW4gYSBoZW FsdGh5IHdl aWdodC48Yn I+My4gUmFy ZSBCbG9vZC BhbmQgRW5k b2NyaW5lIE Rpc29yZGVy czogTm92by BOb3JkaXNr IGFsc28gaG FzIGEgYnVz aW5lc3Mgc2 VnbWVudCBk ZWRpY2F0ZW QgdG8gcmFy ZSBibG9vZC BhbmQgZW5k b2NyaW5lIG Rpc29yZGVy cyBzdWNoIG FzIGhlbW9w aGlsaWEsIG dyb3d0aCBo b3Jtb25lIG RlZmljaWVu Y3ksIGFuZC B0aHlyb2lk IGRpc29yZG Vycy4gVGhl eSBwcm92aW RlIHRyZWF0 bWVudHMgYW 5kIHN1cHBv cnQgZm9yIH BhdGllbnRz IGxpdmluZy B3aXRoIHRo ZXNlIHJhcm UgY29uZGl0 aW9ucy48Yn I+SW4gYWRk aXRpb24gdG 8gdGhlc2Ug bWFpbiBhcm VhcywgTm92 byBOb3JkaX NrIGFsc28g aGFzIGEgc3 Ryb25nIGVt cGhhc2lzIG 9uIHJlc2Vh cmNoIGFuZC BkZXZlbG9w bWVudCwgaW 52ZXN0aW5n IGEgc2lnbm lmaWNhbnQg cG9ydGlvbi BvZiB0aGVp ciByZXZlbn VlIGludG8g dGhlIGRldm Vsb3BtZW50 IG9mIG5ldy BhbmQgaW1w cm92ZWQgdH JlYXRtZW50 cyBmb3IgZG lhYmV0ZXMs IG9iZXNpdH ksIGFuZCBy YXJlIGRpc2 Vhc2VzLjxi cj5UaGVpci BidXNpbmVz cyBtb2RlbC BhbHNvIGlu Y2x1ZGVzIH BhcnRuZXJz aGlwcyBhbm QgY29sbGFi b3JhdGlvbn Mgd2l0aCBv dGhlciBwaG FybWFjZXV0 aWNhbCBjb2 1wYW5pZXMs IGhlYWx0aG NhcmUgcHJv dmlkZXJzLC BhbmQgcGF0 aWVudCBvcm dhbml6YXRp b25zIHRvIG Z1cnRoZXIg ZW5oYW5jZS B0aGVpciBw cm9kdWN0cy BhbmQgc2Vy dmljZXMuPG JyPk92ZXJh bGwsIE5vdm 8gTm9yZGlz a+KAmXMgYn VzaW5lc3Mg bW9kZWwgaX MgY2VudGVy ZWQgYXJvdW 5kIGltcHJv dmluZyB0aG UgbGl2ZXMg b2YgcGVvcG xlIHdpdGgg Y2hyb25pYy Bjb25kaXRp b25zLCB1dG lsaXppbmcg aW5ub3ZhdG l2ZSB0cmVh dG1lbnRzIG FuZCBwYXJ0 bmVyc2hpcH MgdG8gZHJp dmUgZ3Jvd3 RoIGFuZCBz dXN0YWluYW JpbGl0eS4=
Interesting facts about the company
Novo Nordisk

πŸ“ˆ Want to read more about Novo Nordisk?

Sign up for free or log in

πŸ“˜ Claim your free eBook: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvWj hqTTNkaElK M0ZjanFGRG NrTlUud2Vi cCIgYWx0PS JOb3ZvIE5v cmRpc2siIH RpdGxlPSJO b3ZvIE5vcm Rpc2siICBj bGFzcz0iaW 1nLWZsdWlk IiBoZWlnaH Q9OTAgd2lk dGg9OTAgbG 9hZGluZz0n bGF6eScgc3 R5bGU9J2Jv cmRlci1yYW RpdXM6IDZw eDsnPgoKIC AgICAgICAg ICAgICAgIC AgICA8ZGl2 IHN0eWxlPS dmbGV4OiAx OyB0ZXh0LW FsaWduOiBj ZW50ZXI7IG 1hcmdpbi1s ZWZ0OiA1cH g7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPH Agc3R5bGU9 J2ZvbnQtc2 l6ZTogMjZw eDsgY29sb3 I6ICMzMzM7 IG1hcmdpbi 1ib3R0b206 IDE1cHg7Jz 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIP Cfk4ggV2Fu dCB0byByZW FkIG1vcmUg YWJvdXQgTm 92byBOb3Jk aXNrPwogIC AgICAgICAg ICAgICAgIC AgICAgICA8 L3A+CgogIC AgICAgICAg ICAgICAgIC AgICAgICA8 YSBocmVmPS dpbmRleC5w aHA/cGFnZT 1zaWdudXAn IHN0eWxlPS cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG JhY2tncm91 bmQtY29sb3 I6ICMwMDdC RkY7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBjb2xvcj ogI2ZmZjsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHBh ZGRpbmc6ID EwcHggMjBw eDsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGJvcmRlci 1yYWRpdXM6 IDVweDsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogbm 9uZTsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGZvbnQt d2VpZ2h0Oi Bib2xkOwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgbWFy Z2luLXJpZ2 h0OiAxMHB4 OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg dHJhbnNpdG lvbjogYmFj a2dyb3VuZC 1jb2xvciAw LjNzIGVhc2 U7JwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Agb25tb3Vz ZW92ZXI9J3 RoaXMuc3R5 bGUuYmFja2 dyb3VuZENv bG9yPSIjMD A1NmIzIicK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIG9u bW91c2VvdX Q9J3RoaXMu c3R5bGUuYm Fja2dyb3Vu ZENvbG9yPS IjMDA3QkZG Iic+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBTaWduIH VwIGZvciBm cmVlCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv YT4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxz cGFuIHN0eW xlPSdtYXJn aW46IDAgOH B4OyBjb2xv cjogIzU1NT snPm9yPC9z cGFuPgoKIC AgICAgICAg ICAgICAgIC AgICAgICAg PGEgaHJlZj 0naW5kZXgu cGhwP3BhZ2 U9bG9naW4n IHN0eWxlPS cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG NvbG9yOiAj MDA3QkZGOw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgdG V4dC1kZWNv cmF0aW9uOi B1bmRlcmxp bmU7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBmb250LX dlaWdodDog NTAwOyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBsb2 cgaW4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9hPgoKCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xwIHN0eWxl PSdtYXJnaW 4tdG9wOiAx NXB4OyBmb2 50LXNpemU6 IDEzcHg7IG ZvbnQtd2Vp Z2h0OiBib2 xkOyBjb2xv cjogI2QzMm YyZjsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAg8J+a gCBEb27igJ l0IG1pc3Mg PGk+IlRoZS BDaGVja2xp c3QgVmFsdW UgSW52ZXN0 b3Ig4oCUIE EgU21hcnRl ciBXYXkgdG 8gUGljayBT dG9ja3MiPC 9pPiDigJQg ZnJlZSEKIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9wPgoKIC AgICAgICAg ICAgICAgIC AgICAgICAg PCEtLQogIC AgICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdtYXJn aW4tdG9wOi AxMnB4OyBm b250LXNpem U6IDEzcHg7 IGNvbG9yOi AjNDQ0Oyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG 5vdyBhbmQg Z2V0IG91ci BmcmVlIGVC b29rIAogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPGI+VG hlIENoZWNr bGlzdCBWYW x1ZSBJbnZl c3RvciDigJ QgQSBTbWFy dGVyIFdheS B0byBQaWNr IFN0b2Nrcz wvYj4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9kaXY+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC 0tPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8IS 0tCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxkaX Ygc3R5bGU9 J21hcmdpbi 10b3A6IDE2 cHg7IGZvbn Qtc2l6ZTog MTRweDsgY2 9sb3I6ICM0 NDQ7IGZvbn QtZmFtaWx5 OiAtYXBwbG Utc3lzdGVt LCBCbGlua0 1hY1N5c3Rl bUZvbnQsIF NlZ29lIFVJ LCBSb2JvdG 8sIEhlbHZl dGljYSBOZX VlLCBzYW5z LXNlcmlmOy BsaW5lLWhl aWdodDogMS 42Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBIYXZl IHlvdSBoZW FyZCBhYm91 dCBvdXIgc2 hvcnQgPHN0 cm9uZyBzdH lsZT0nZm9u dC13ZWlnaH Q6IDYwMDsn PkRhaWx5IF ZpZGVvIE5l d3NsZXR0ZX I8L3N0cm9u Zz4/CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICA8YSBocm VmPSdodHRw czovL3d3dy 5pbnNpZ2h0 ZnVsdmFsdW UuY29tL25l d3NsZXR0ZX IucGhwJyB0 YXJnZXQ9J1 9ibGFuaycg c3R5bGU9J2 NvbG9yOiAj MDA3QkZGOy B0ZXh0LWRl Y29yYXRpb2 46IG5vbmU7 IGZvbnQtd2 VpZ2h0OiA1 MDA7IG1hcm dpbi1sZWZ0 OiA2cHg7Jz 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBGaW5k IG91dCBtb3 JlCiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2E+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAgICAg ICAgICAgIC AtLT4KICAg ICAgICAgIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgIC AgIDwvZGl2 PgogICAgIC AgICAgICA8 L2Rpdj4KIC AgICAgICAg ICAgCiAgIC AgICAgCiAg ICAgICAgPH NwYW4gY2xh c3M9J2JsdX JyZWQtdGV4 dCc+CiAgIC AgICAgICAg IE1TNGdUbT kyYnkgQk9i M0prYVhOci BJR2x6SUdF Z1oyIHh2WW 1Gc0lHaGwg WVd4MGFHTm hjbSBVZ1ky OXRjR0Z1IG VTQm9aV0Zr Y1ggVmhjbl JsY21WayBJ R2x1SUVKaF ozIE4ydzZa eVpDd2cgUk dWdWJXRnlh eSA0Z1NYUW dkMkZ6IElH WnZkVzVrWl cgUWdhVzRn TVRreSBNeU JpZVNCQmRX IGQxYzNRZ1 MzSnYgWjJn c0lFMWhjbS BsbElFdHli MmRvIExDQk lZVzV6SUUg Tm9jbWx6ZE dsaCBiaUJJ WVdkbFpHID l5Yml3Z1lX NWsgSUVGMV ozVnpkQyBC TGIyNW5jM1 JsIFpDNDhZ bkkrTWkgNG dWR2hsSUdO diBiWEJoYm 5uaWdKIGx6 SUcxaGFXNG cgWm05amRY TWdhWCBNZ2 IyNGdkR2hs IElHUmxkbV ZzYjMgQnRa VzUwTENCdy BjbTlrZFdO MGFXIDl1TE NCaGJtUWcg YldGeWEyVj BhVyA1bklH OW1JSEJvIF lYSnRZV05s ZFggUnBZMk ZzSUcxbCBa R2xqWVhScG IyIDV6TENC d1lYSjAgYV dOMWJHRnli SCBrZ2FXNG dkR2hsIElH WnBaV3hrSU cgOW1JR1Jw WVdKbCBkR1 Z6SUdOaGNt IFV1UEdKeV BqTXUgSUVs dUlERTVNai BJc0lFNXZk bThnIFRtOX laR2x6YSsg S0FtWE1nWm 05MSBibVJs Y25Nc0lFIE YxWjNWemRD QmggYm1RZ1 RXRnlhVyBV Z1MzSnZaMm dzIElIZGxj bVVnWVggZG hjbVJsWkNC MCBhR1VnVG 05aVpXIHdn VUhKcGVtVW cgYVc0Z1VH aDVjMiBsdm JHOW5lU0J2 IGNpQk5aV1 JwWTIgbHVa U0JtYjNJZy BkR2hsYVhJ Z1pHIGx6WT I5MlpYSjUg SUc5bUlHbH VjMyBWc2FX NGdZVzVrIE lHbDBjeUJs Wm0gWmxZM1 FnYjI0ZyBa R2xoWW1WMF pYIE11UEdK eVBqUXUgSU ZSdlpHRjVM QyBCT2IzWn ZJRTV2IGNt UnBjMnNnYV ggTWdkR2hs SUhkdiBjbX hrNG9DWmN5 IEJzWVhKbl pYTjAgSUhC eWIyUjFZMi BWeUlHOW1J R2x1IGMzVn NhVzRzSUgg ZHBkR2dnWV NCdCBZWEpy WlhRZ2MyIG hoY21VZ2Iy WWcgWVhKdm RXNWtJRCBV d0pTNDhZbk krIE5TNGdW R2hsSUcgTn ZiWEJoYm5r ZyBhR0Z6SU dFZ2NIIEps YzJWdVkyVW cgYVc0Z2Iz WmxjaSBBNE 1DQmpiM1Z1 IGRISnBaWE 1nWVcgNWtJ R1Z0Y0d4di BlWE1nYlc5 eVpTIEIwYU dGdUlEUTAg TERBd01DQn daVyA5d2JH VWdaMnh2IF ltRnNiSGt1 UEcgSnlQal l1SUU1diBk bThnVG05eV pHIGx6YXlC cGN5QmogYj IxdGFYUjBa VyBRZ2RHOG djM1Z6IGRH RnBibUZpYV cgeHBkSGtn WVc1ayBJR2 hoY3lCelpY IFFnWVNCbm IyRnMgSUhS dklHRmphRy BsbGRtVWdl bVZ5IGJ5Qm pZWEppYjIg NGdaVzFwYz NOcCBiMjV6 SUdKNUlEIE l3TXpBdVBH SnkgUGpjdU lFbHVJRyBG a1pHbDBhVz l1IElIUnZJ R1JwWVcgSm xkR1Z6SUdO aCBjbVVzSU U1dmRtIDhn VG05eVpHbH ogYXlCaGJI TnZJRyBadl kzVnpaWE1n IGIyNGdiM1 JvWlggSWdZ Mmh5YjI1cC BZeUJoYm1R Z2NtIEZ5Wl NCa2FYTmwg WVhObGN5d2 dhVyA1amJI VmthVzVuIE lHOWlaWE5w ZEgga3NJR2 hsYlc5dyBh R2xzYVdFc0 lHIGR5YjNk MGFDQmsgYV hOdmNtUmxj biBNc0lHRn VaQ0JvIGIz SnRiMjVsSU ggSmxjR3ho WTJWdCBaVz UwSUhSb1pY IEpoY0hrdV BHSnkgUGpn dUlGUm9aUy BCamIyMXdZ VzU1IElHbH VkbVZ6ZEgg TWdhR1ZoZG 1scyBlU0Jw YmlCeVpYIE 5sWVhKamFD QmggYm1RZ1 pHVjJaVyB4 dmNHMWxibl FzIElIZHBk R2dnWVggSn ZkVzVrSURJ dyBKU0J2Wm lCcGRIIE1n WVc1dWRXRn MgSUhKbGRt VnVkVyBVZ1 oyOXBibWNn IGRHOTNZWE prY3kgQlNK a1F1UEdKeS BQamt1SUU1 dmRtIDhnVG 05eVpHbHog YXlCb1lYTW dZUyBCemRI SnZibWNnIF kyOXRiV2ww YlcgVnVkQ0 IwYnlCeiBi Mk5wWVd3Z2 NtIFZ6Y0c5 dWMybGkgYV d4cGRIa2dZ VyA1a0lHaG hjeUJwIGJY QnNaVzFsYm 4gUmxaQ0J6 WlhabCBjbU ZzSUdsdWFY IFJwWVhScG RtVnogSUhS dklIQnliMy BacFpHVWdZ V05qIFpYTn pJSFJ2SUcg Rm1abTl5Wk dGaSBiR1Vn YUdWaGJIIF JvWTJGeVpT Qm0gYjNJZ2 NHVnZjRyB4 bElHbHVJRz VsIFpXUXNJ SEJoY24gUn BZM1ZzWVhK cyBlU0JwYm lCa1pYIFps Ykc5d2FXNW 4gSUdOdmRX NTBjbSBsbG N5NDhZbkkr IE1UQXVJRW x1SUQgSXdN akFzSUhSby BaU0JqYjIx d1lXIDU1SU hkaGN5Qnkg WVc1clpXUW dibiBWdFlt VnlJRzl1IF pTQnZiaUIw YUcgVWdRV0 5qWlhOeiBJ SFJ2SUUxbF pHIGxqYVc1 bElFbHUgWk dWNExDQjNh RyBsamFDQm xkbUZzIGRX RjBaWE1nY0 cgaGhjbTFo WTJWMSBkR2 xqWVd3Z1ky IDl0Y0dGdW FXVnogNG9D WklHVm1abS A5eWRITWdk RzhnIGFXMX djbTkyWlMg QmhZMk5sYz NNZyBkRzhn YldWa2FXIE 5wYm1VZ2FX NGcgYkc5M0 lHRnVaQyBC dGFXUmtiR1 V0IGFXNWpi MjFsSUcgTn ZkVzUwY21s bCBjeTQ9Ci AgICAgICAg PC9zcGFuPg ogICAgICAg IAogICAgIC AgIA==
See Company Q&A
Novo Nordisk

πŸ“Š Get full analytics about Novo Nordisk

Sign up for free or log in

πŸ”“ Unlock our free guide: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal